Polish researchers say long-term control of allergic asthma can occur after only three years of allergy shots -- not the recommended three to five years. Dr. Iwona Stelmach of the Medical University of Lodz in Poland and colleagues said immunotherapy, or allergy shots, can alter the progression of allergic disease. Treatment, Stelmach said, alleviates patients of symptoms, while preventing asthma and the development of other allergies. \"The recommended duration of immunotherapy for long-term effectiveness has been three to five years,\" Stelmach, the study\'s lead author, said in a statement. \"Our research shows that three years is an adequate duration for the treatment of childhood asthma associated with house dust mites. An additional two years adds no clinical benefit.\" Dr. James Sublett, an allergist who is chairman of the American College of Allergy, Asthma and Immunology\'s Indoor Environment Committee, said not only does the shorter period of shots provide long-term therapeutic benefits for both children and adults, it can reduce total healthcare costs by 33 percent to 41 percent. \"It has long been observed that the effectiveness of allergy shots continue long after treatment has been completed,\" Sublett said. \" The findings were published in the of the Annals of Allergy, Asthma and Immunology.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor